$A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies$

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

10.1007/s11523-023-00962-w

Saved in:

Bibliographic Details
Main Authors:	Chee, Cheng E, Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline SJ, Tan, David SP, Soo, Ross, Tan, Joshua TC, Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	SPRINGER 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology PRL-3 PHOSPHATASE METASTASIS
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239257
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-239257
record_format	dspace
spelling	sg-nus-scholar.10635-2392572025-01-11T03:03:34Z A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies Chee, Cheng E Ooi, Melissa Lee, Soo-Chin Sundar, Raghav Heong, Valerie Yong, Wei-Peng Ng, Chin Hin Wong, Andrea Lim, Joline SJ Tan, David SP Soo, Ross Tan, Joshua TC Yang, Song Thura, Min Al-Aidaroos, Abdul Qader Chng, Wee Joo Zeng, Qi Goh, Boon-Cher MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE INSTITUTE OF MOLECULAR & CELL BIOLOGY Dr Cheng Ean Chee Science & Technology Life Sciences & Biomedicine Oncology PRL-3 PHOSPHATASE METASTASIS 10.1007/s11523-023-00962-w TARGETED ONCOLOGY completed 2023-05-09T08:30:31Z 2023-05-09T08:30:31Z 2023-04-15 2023-05-09T08:04:07Z Article Chee, Cheng E, Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline SJ, Tan, David SP, Soo, Ross, Tan, Joshua TC, Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher (2023-04-15). A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies. TARGETED ONCOLOGY. ScholarBank@NUS Repository. https://doi.org/10.1007/s11523-023-00962-w 1776-2596 1776-260X https://scholarbank.nus.edu.sg/handle/10635/239257 en SPRINGER Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Oncology PRL-3 PHOSPHATASE METASTASIS
spellingShingle	Science & Technology Life Sciences & Biomedicine Oncology PRL-3 PHOSPHATASE METASTASIS Chee, Cheng E Ooi, Melissa Lee, Soo-Chin Sundar, Raghav Heong, Valerie Yong, Wei-Peng Ng, Chin Hin Wong, Andrea Lim, Joline SJ Tan, David SP Soo, Ross Tan, Joshua TC Yang, Song Thura, Min Al-Aidaroos, Abdul Qader Chng, Wee Joo Zeng, Qi Goh, Boon-Cher A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
description	10.1007/s11523-023-00962-w
author2	MEDICINE
author_facet	MEDICINE Chee, Cheng E Ooi, Melissa Lee, Soo-Chin Sundar, Raghav Heong, Valerie Yong, Wei-Peng Ng, Chin Hin Wong, Andrea Lim, Joline SJ Tan, David SP Soo, Ross Tan, Joshua TC Yang, Song Thura, Min Al-Aidaroos, Abdul Qader Chng, Wee Joo Zeng, Qi Goh, Boon-Cher
format	Article
author	Chee, Cheng E Ooi, Melissa Lee, Soo-Chin Sundar, Raghav Heong, Valerie Yong, Wei-Peng Ng, Chin Hin Wong, Andrea Lim, Joline SJ Tan, David SP Soo, Ross Tan, Joshua TC Yang, Song Thura, Min Al-Aidaroos, Abdul Qader Chng, Wee Joo Zeng, Qi Goh, Boon-Cher
author_sort	Chee, Cheng E
title	A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
title_short	A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
title_full	A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
title_fullStr	A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
title_full_unstemmed	A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
title_sort	phase i, first-in-human study of prl3-zumab in advanced, refractory solid tumors and hematological malignancies
publisher	SPRINGER
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/239257
_version_	1821833167706783744

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

Similar Items